Ceterix® Orthopaedics is singularly focused on meniscal preservation and is dedicated to providing patients every opportunity to maintain the natural health and stability of their knee. The NovoStitch® Pro Meniscal Repair System, our flagship product, provides surgeons the unique ability to repair a variety of meniscal tear types that currently remain untreated or are treated by meniscectomy (meniscus removal), a procedure associated with increased risk of arthritis or total knee replacement later in life. Based in Fremont, Calif., the company is backed by investors Novo Ventures, Versant Ventures, and 5AM Ventures.